tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
Want to see EDIT full AI Analyst Report?

Compare Editas Medicine (EDIT) vs. Competitors

3,558 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$3.49
$293.62M
-1.14
79.01%
4 Buy
3 Hold
1 Sell
Moderate Buy
Cellectis SA
$4.42
$282.06M
-7.16
144.89%
1 Buy
0 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$5.29
$278.83M
-4.58
14.42%
7 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$13.55
$198.64M
-3.95
114.14%
4 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$16.59
$699.98M
-0.19
4.77%
5 Buy
1 Hold
0 Sell
Strong Buy
Caribou Biosciences
$2.20
$182.27M
-1.42
133.46%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
2.90
1.36
88.31%
CLLS
Cellectis SA
3.95
2.35
146.88%
FHTX
Foghorn Therapeutics
4.76
0.88
22.68%
ELTX
Elicio Therapeutics
10.75
5.34
98.71%
VOR
Vor Biopharma
13.85
1.76
14.56%
CRBU
Caribou Biosciences
1.87
1.01
117.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts